Trial · NCT07882186
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Survey to Estimate Vaccination Coverage Against Pertussis, COVID-19, Seasonal Influenza, and RSV Infection Among Pregnant Women in Maternity Units in the Île-de-France Region. | Day 0 | Proportion of women vaccinated against pertussis, COVID-19, seasonal influenza, and RSV infection during pregnancy, by department type and by maternity unit type, and then estimate the proportion of vaccinated women across the entire Île-de-France region. |
| Secondary | Survey to determine the proportion of newborns who received RSV immunization through the administration of specific monoclonal antibodies | Day 0 | Proportion of newborns immunized against RSV through administration of specific monoclonal antibodies, born to mothers who were not vaccinated against RSV during pregnancy. |
| Secondary | Survey to assess knowledge of vaccination recommendations for pertussis, COVID-19, RSV, and seasonal influenza during pregnancy | Day 0 | Proportion of women aware of vaccination recommendations against pertussis, COVID-19, seasonal influenza, and RSV during pregnancy, and their sources of information. |
| Secondary | Questionnaire aimed at assessing the proportion of women who are aware of the recommendation for preventive immunization of newborns against RSV as well as identifying their main sources of information. | Day 0 | Proportion of women aware of the recommendation for pre-exposure immunization against RSV through administration of monoclonal antibodies-nirsevimab (Beyfortus®) or palivizumab (Synagis®)-to the newborn, and their sources of information. |
| Secondary | Questionnaire to Identify Factors Associated with Vaccination Against Pertussis, COVID-19, Seasonal Influenza, and RSV During Pregnancy | Day 0 | Vaccination status, knowledge of the listed infections, knowledge of vaccines, vaccination pathway, socio-demographic and socio-economic factors, category of healthcare professional providing pregnancy care. |
| Secondary | Questionnaire to identify factors associated with pre-exposure vaccination against RSV through the administration of monoclonal antibodies to newborns | Day 0 | Factors associated with pre-exposure immunization against RSV through administration of monoclonal antibodies-nirsevimab (Beyfortus®) or palivizumab (Synagis®)-to the newborn. |
| Secondary | Questionnaire to assess the acceptability of vaccination against pertussis, COVID-19, and seasonal influenza in the context of a future pregnancy. | Day 0 | Proportion of women who accepted vaccination against pertussis, COVID-19, and/or seasonal influenza during their pregnancy and who would accept the same vaccination(s) again in a future pregnancy. |
| Secondary | Questionnaire to assess the acceptability of various strategies for preventing RSV and bronchiolitis in newborns in the context of a future pregnancy or birth | Day 0 | Proportion of women whose newborn was immunized against RSV and who would accept either RSV immunization strategy in a future pregnancy/birth |
| Secondary | For women not vaccinated against pertussis during pregnancy, assess: • Reasons for non-vaccination against pertussis. • Acceptability of vaccination against pertussis during pregnancy and postpartum. • Barriers to vaccination against pertussis. | Day 0 | Proportion of women not vaccinated against COVID-19, seasonal influenza, and/or RSV during pregnancy who: i) would have accepted one or more of these vaccinations during that pregnancy, ii) would accept one or more of these vaccinations in a future pregnancy. |
| Secondary | Survey to determine the proportion of women who were not vaccinated against COVID-19, seasonal flu, and/or RSV during their pregnancy and who would have agreed or would agree to receive one or more of these vaccines | Day 0 | Proportion of women not vaccinated against COVID-19, seasonal influenza, and/or RSV during pregnancy who: I) would have accepted one or more of these vaccinations during that pregnancy, II) would accept one or more of these vaccinations in a future pregnancy. |
| Secondary | Questionnaire to assess the acceptability of various strategies for preventing RSV and bronchiolitis in newborns in the context of a future pregnancy or birth | Day 0 | Proportion of women whose newborn was not immunized against RSV who: I) would have accepted either RSV immunization strategy during this pregnancy/birth, II) would accept either RSV immunization strategy in a future pregnancy/birth. |
| Secondary | Questionnaire to assess the reasons for non-vaccination during pregnancy | Day 0 | Reasons for non-vaccination against pertussis, COVID-19, seasonal influenza, and RSV during pregnancy (not offered/refusal/other). |
| Secondary | Survey to describe the vaccination history of pregnant women regarding pertussis, COVID-19, seasonal flu, and RSV | Day 0 | For women vaccinated during pregnancy: * Professional category and practice setting of the healthcare professional who prescribed the vaccination to the pregnant woman (physician, nurse, midwife, pharmacist; maternity unit or community setting). * Professional category and practice setting of the healthcare professional who administered the vaccination to the pregnant woman (physician, nurse, midwife, pharmacist; maternity unit or community setting). |
| Secondary | Survey to determine the vaccination coverage rate for pertussis, seasonal flu, and COVID-19. | Day 0 | Proportion of vaccinating healthcare professionals up to date with their own vaccinations against pertussis, COVID-19, and seasonal influenza. |
| Secondary | Questionnaire to Identify Factors Associated with Pertussis, COVID-19, and Seasonal Flu Vaccinations Administered by Primary Care Providers | Day 0 | Vaccination status, knowledge of the listed infections, knowledge of vaccines, vaccination pathway, socio-demographic and socio-economic factors. |
| Secondary | Questionnaire to assess knowledge of vaccination recommendations for pertussis, COVID-19, seasonal influenza, and RSV during pregnancy. | Day 0 | Proportion of vaccinating healthcare professionals aware of vaccination recommendations against pertussis, COVID-19, seasonal influenza, and RSV during pregnancy, and their sources of information. |
| Secondary | Questionnaire to assess whether healthcare professionals are offering recommended vaccines to pregnant women | Day 0 | Proportion of vaccinating healthcare professionals offering vaccinations against pertussis, COVID-19, seasonal influenza, and RSV to pregnant women. |
| Secondary | Surveys to assess how often healthcare professionals responsible for vaccinations prescribe vaccines during pregnancy. | Day 0 | Frequency with which vaccinating healthcare professionals prescribe vaccinations against pertussis, COVID-19, seasonal influenza, and RSV during pregnancy (never, sometimes, often, always). |
| Secondary | Questionnaire to assess the factors associated with prescribing vaccines "often" or "always" during pregnancy. | Day 0 | Factors associated with "often" or "always" prescribing vaccinations against pertussis, COVID-19, seasonal influenza, and RSV to pregnant women (vaccination status of the healthcare professional for influenza, pertussis, and COVID-19; knowledge of the healthcare professional regarding pertussis; knowledge of the healthcare professional regarding national vaccination recommendations for pregnant women). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07882186/registered